Wednesday, July 2, 2025 7/2/2025

Uncovering the two-partner secretion mechanism and novel antimicrobials

Award Number: R21AI180112
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 12/01/2023
PERIOD OF PERFORMANCE END DATE: 10/31/2025

Group Awards By:

View Award Description

Uncovering the two-partner secretion mechanism and novel antimicrobials - Pertussis is a re-emerging public health concern, and its resurgence is correlated with a switch from whole-cell to acellular vaccines, which prevent disease, but not colonization or transmission of the causative agent Bordetella pertussis. In order to limit the mortality and morbidity associated with pertussis, particularly in infants, a combination of more effective vaccines and antibiotic therapies are needed. Their development requires a better understanding of the molecular basis for Bordetella pertussis pathogenicity. We are proposing experiments that will answer longstanding questions regarding the secretory mechanism of Filamentous hemagglutinin (FhaB), a critical virulence factor for Bordetella pertussis and to identify peptides which inhibit FhaB secretion. FhaB mediates adherence to mammalian respiratory epithelial cells, suppresses the inflammatory response and is required for Bordetella to persist in the murine respiratory tract. FhaB is a TpsA protein secreted by the TpsB protein FhaC. FhaBC are the model for two-partner secretion (TPS) systems. TPS systems are broadly distributed among Gram-negative bacteria and many have proven or postulated roles in virulence. TpsB proteins are part of the Omp85 superfamily which also includes outer membrane protein assembly factors such BamA. Due to the complex topology and large size of FhaB and other TpsA effectors, no structures of active TpsB transporters in complex with their effectors have been solved. The lack of structural information has limited our understanding of how TpsB proteins interact with TpsA passengers and complicates the design of effective anti-microbials targeting these systems. We propose to: 1) Determine the mechanism and structure of the early stages of FhaB secretion by FhaC using a simplified FhaB/FhaC system that we have developed in E. coli and 2) screen a large library (>1012) of cyclic peptides to identify those that bind and inhibit FhaC. This is a collaborative project that takes advantage of the expertise and resources of the Cotter and Doyle laboratories. The results of this work will lay the foundation for a substantial collaboration between the two groups investigating the molecular basis for the TPS mechanism and identification of antimicrobial compounds targeting these systems in Gram negative pathogens.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $159,977 )
2025	2025	UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL	104 AIRPORT DR STE 2200	CHAPEL HILL	NC	27599	ORANGE	USA	Allergy and Infectious Diseases Research	000	2	10/30/2024	NON-COMPETING CONTINUATION	$159,977
														Subtotal = $159,977

Issue Date FY: 2024 ( Subtotal = $211,500 )
2024	2024	UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL	104 AIRPORT DR STE 2200	CHAPEL HILL	NC	27599	ORANGE	USA	Allergy and Infectious Diseases Research	000	1	11/30/2023	NEW	$190,350
2024	2024	UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL	104 AIRPORT DR STE 2200	CHAPEL HILL	NC	27599	ORANGE	USA	Allergy and Infectious Diseases Research	001	1	9/11/2024	NEW	$21,150
														Subtotal = $211,500

Grand Total All Awards = $371,477

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Uncovering the two-partner secretion mechanism and novel antimicrobials

Award Number: R21AI180112

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 12/01/2023

PERIOD OF PERFORMANCE END DATE: 10/31/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer